NSTEMI Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about NSTEMI clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone

Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MISTEMI (ST Elevation MI)
Montreal Heart Institute2,570 enrolled1 locationNCT07257198
Recruiting

Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

Coronary Arterial Disease (CAD)NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)Stable Angina, Unstable Angina, NSTEMI
Fundación Interhospitalaria para la Investigación Cardiovascular FIC1,118 enrolled1 locationNCT07444957
Recruiting
Phase 3

DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

Left Ventricular DysfunctionSTEMIAMI+1 more
Assistance Publique - Hôpitaux de Paris450 enrolled1 locationNCT05764057
Recruiting
Not Applicable

Breaking Fasts Ahead of Cardiac Caths

NSTEMI - Non-ST Segment Elevation MIUnstable Angina (UA)Stable Angina (SA)
University of South Florida400 enrolled1 locationNCT06996639
Recruiting

TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome

Myocardial Infarction (MI)Inflammation BiomarkersSTEMI+3 more
University Hospital Centre Mother Teresa1,600 enrolled1 locationNCT07026708
Recruiting
Phase 4

Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction

Acute Myocardial Infarction (AMI)NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
University of Aarhus5,076 enrolled1 locationNCT06710184
Recruiting

AI Algorithms in Prediction of ACS Based on Leukocyte Properties

Acute Coronary SyndromeAngina PectorisSTEMI - ST Elevation Myocardial Infarction+1 more
RobotDreams GmbH2,700 enrolled1 locationNCT06384846
Recruiting
Phase 4

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Atrial FibrillationStrokeAcute Coronary Syndrome+8 more
St. Antonius Hospital2,000 enrolled20 locationsNCT04436978
Recruiting

OPTIMISER Registry - A Prospective Cohort Study to Describe the OPTIMal Management and Outcomes of PatIents PreSEnting With Acute MyocaRdial Infarction

Myocardial IschemiaMyocardial InfarctionSTEMI+1 more
Luzerner Kantonsspital4,000 enrolled1 locationNCT04988672